SQI Diagnostics Inc.

SQI Diagnostics Inc., a company dedicated to precision medicine, specializes in the research, development, and global commercialization of expedited diagnostic testing solutions. These offerings cater to medical professionals, patients, and individual consumers alike. Among its diverse portfolio, the company offers TOR-dx, a specialized lung assessment tool that aids surgeons in evaluating the viability of donor lungs. Additionally, SQI Diagnostics provides an at-home antibody test kit for COVID-19, alongside two distinct tests for gauging COVID-19 severity: the RALI-Dx, a laboratory-based triage solution, and the RALI-fast, designed for point-of-care assessment. The company also manufactures microarray instruments, integral to various antibody testing workflows. Established in 1999, SQI Diagnostics Inc. maintains its corporate headquarters in Toronto, Canada.